Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3003545 | 1.00 | MEN1 (0.36) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL822546 | 0.98 | EPHX1 (0.33) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2223475 | 0.93 | EPHX1 (0.34) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL12677034 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL1594114 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL1582321 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL7087398 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL14655776 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL213891 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL214950 | 0.91 | ALDH1A1 (0.33) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293448-B2 | Resin composition for stereolithography | CMET INC. (JP) | 2012-10-23 | — | — | US | claimed |
| US-12624247-B2 | Film | LG CHEM, LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| EP-3433086-B1 | ENERGETIC MATERIALS | TNO (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-3787878-B1 | METHODS OF POST-PROCESSING PHOTOFABRICATED ARTICLES CREATED VIA ADDITIVE FABRICATION | STRATASYS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-3917445-B1 | METHODS OF MAKING AND POSTPROCESSING ORTHODONTIC ARTICLES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250306464-A1 | COMPOSITION FOR FORMING FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, MONOMER, AND POLYMER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4625045-A2 | COMPOSITION FOR FORMING FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, MONOMER, AND POLYMER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-12378425-B2 | Thermosetting compositions and forming three-dimensional objects therefrom | STRATASYS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| EP-2868692-B2 | Stabilized matrix-filled liquid radiation curable resin compositions for additive fabrication | STRATASYS INC (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025132333-A1 | CURABLE COMPOSITIONS INCLUDING A POLYESTER (METH)ACRYLATE OLIGOMER | ARKEMA FRANCE (FR) | 2025-06-26 | — | — | WO | disclosed |
| US-8247583-B2 | 3-ethyloxethane compound having hydroxyl group and method for producing the same | UBE INDUSTRIES, LTD. (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-2396299-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | DSM IP Assets B.V. (NL) | 2011-12-21 | — | — | EP | disclosed |
| WO-2011091228-A1 | LIQUID RADIATION CURABLE RESINS CAPABLE OF CURING INTO LAYERS WITH SELECTIVE VISUAL EFFECTS AND METHODS FOR THE USE THEREOF | DSM IP ASSETS B.V. (NL) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011084578-A1 | SUBSTRATE-BASED ADDITIVE FABRICATION PROCESS | DSM IP ASSETS, B.V. (NL) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011075553-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | DSM IP ASSETS, B.V. (NL) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075555-A1 | LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP ASSETS, B.V. (NL) | 2011-06-23 | — | — | WO | disclosed |
| US-20100174098-A1 | 3-ETHYLOXETHANE COMPOUND HAVING HYDROXYL GROUP AND METHOD FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2010-07-08 | — | — | US | disclosed |
| US-20090209674-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | CMET INC. (JP) | 2009-08-20 | — | — | US | disclosed |
| EP-2033982-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | Cmet Inc. (JP) | 2009-03-11 | — | — | EP | disclosed |
| EP-2030972-A1 | 3-ETHYLOXETHANE COMPOUND HAVING HYDROXYL GROUP AND METHOD FOR PRODUCING THE SAME | Ube Industries, Ltd. (JP) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624247-B2 | Film | RAD51, COL2A1, COL1A1 | MEN1 2777/4885KMT2A 3180/4885THRB 441/4885 |
| US-20100174098-A1 | 3-ETHYLOXETHANE COMPOUND HAVING HYDROXYL GROUP AND METHOD FOR PRODUCING THE SAME | CYP2E1, CYP11B2, EGLN3 | MEN1 2026/4885KMT2A 3503/4885THRB 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.